Penumbra Company Profile (NYSE:PEN)

About Penumbra

Penumbra logoPenumbra, Inc. (Penumbra) is an interventional therapies company. The Company designs, develops, manufactures and markets medical devices. The Company has a portfolio of products that addresses medical conditions and significant clinical needs across two markets, neuro and peripheral vascular. The conditions that its products address include ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. The Company focuses on developing, manufacturing and marketing products for use by specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists and vascular surgeons. Its neuro products include Neurovascular Access, Ischemic Stroke, Neurovascular Embolization and Neurosurgical Tools. The Company's peripheral vascular products include Peripheral Embolization and Peripheral Thrombectomy.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: PEN
  • CUSIP:
Key Metrics:
  • Previous Close: $76.96
  • 50 Day Moving Average: $72.52
  • 200 Day Moving Average: $58.91
  • 52-Week Range: $35.31 - $79.49
  • Trailing P/E Ratio: 999.48
  • Foreward P/E Ratio: Infinity
  • P/E Growth: -10.05
  • Market Cap: $2.39B
  • Outstanding Shares: 31,054,000
Profitability:
  • Net Margins: 1.54%
  • Return on Equity: 1.48%
  • Return on Assets: 1.29%
Debt:
  • Current Ratio: 8.09%
  • Quick Ratio: 5.96%
Additional Links:
Companies Related to Penumbra:

Analyst Ratings

Consensus Ratings for Penumbra (NYSE:PEN) (?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $53.00 (31.13% downside)

Analysts' Ratings History for Penumbra (NYSE:PEN)
Show:
DateFirmActionRatingPrice TargetDetails
7/20/2016Canaccord GenuitySet Price TargetBuy$67.00View Rating Details
3/14/2016Wells Fargo & Co.Reiterated RatingOutperformView Rating Details
10/13/2015Bank of America Corp.Initiated CoverageBuy -> Buy$46.00 -> $46.00View Rating Details
10/13/2015JPMorgan Chase & Co.Initiated CoverageOverweight$46.00View Rating Details
(Data available from 9/27/2014 forward)

Earnings

Earnings History for Penumbra (NYSE:PEN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/9/2016Q216($0.07)$0.01$58.18 million$65.10 millionViewN/AView Earnings Details
5/9/2016Q116($0.07)$0.02$53.10 million$57.90 millionViewN/AView Earnings Details
3/8/2016Q415($0.10)$0.05$46.76 million$54.40 millionViewN/AView Earnings Details
11/12/2015Q315($0.15)$0.03$43.00 million$50.42 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Penumbra (NYSE:PEN)
Current Year EPS Consensus Estimate: $-0.23 EPS

Dividends

Dividend History for Penumbra (NYSE:PEN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Penumbra (NYSE:PEN)
Insider Ownership Percentage: 22.00%
Institutional Ownership Percentage: 51.96%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/9/2016Adam ElsesserCEOSell57,200$71.07$4,065,204.00View SEC Filing  
9/6/2016Arani BoseInsiderSell61,000$70.72$4,313,920.00View SEC Filing  
9/2/2016Robert D EvansEVPSell3,100$70.10$217,310.00View SEC Filing  
8/31/2016Adam ElsesserCEOSell26,000$71.15$1,849,900.00View SEC Filing  
8/31/2016Robert D EvansEVPSell5,300$71.17$377,201.00View SEC Filing  
8/26/2016Adam ElsesserCEOSell26,800$71.06$1,904,408.00View SEC Filing  
8/26/2016Robert D EvansEVPSell5,300$71.03$376,459.00View SEC Filing  
8/24/2016Adam ElsesserCEOSell29,000$72.95$2,115,550.00View SEC Filing  
8/24/2016Robert D EvansEVPSell6,300$73.00$459,900.00View SEC Filing  
5/23/2016Robert D EvansEVPSell5,000$50.52$252,600.00View SEC Filing  
5/19/2016Don W KassingDirectorSell3,000$48.63$145,890.00View SEC Filing  
5/19/2016Robert D EvansEVPBuy1,538$25.50$39,219.00View SEC Filing  
5/16/2016James Robert PrayInsiderSell32,500$48.51$1,576,575.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Penumbra (NYSE:PEN)
DateHeadline
News IconCould Penumbra Inc Skyrocket Even More? The Stock Just Made All-Time High - Post News (NYSE:PEN)
www.kentuckypostnews.com - September 23 at 6:13 PM
einnews.com logoGlobal Brain Ischemia Market Insights, Key Vendors, Competitive Analysis and Forecast Report 2027 (NYSE:PEN)
www.einnews.com - September 22 at 6:23 PM
News IconAnalyst Consensus Estimates & Projections are in For Shares of Penumbra Inc (NYSE:PEN) - Frisco Fastball (NYSE:PEN)
friscofastball.com - September 22 at 11:34 AM
News IconWhat Analyst told about: Organovo Holdings, Inc. (NASDAQ:ONVO) , Penumbra, Inc. (NYSE:PEN) - Wall Street Times (press release) (NYSE:PEN)
www.wallstreetnews24.com - September 22 at 11:34 AM
News IconSizzling Stock- Penumbra, Inc.'s (PEN) - Hot Stocks Point (NYSE:PEN)
www.hotstockspoint.com - September 22 at 11:34 AM
News IconFinal Six Late-Breaking Endovascular Clinical Trial Results Announced at VIVA 16 (NYSE:PEN)
www.advfn.com - September 21 at 6:21 PM
prnewswire.com logoNeurointerventional Devices Market: Global Industry Analysis and Opportunity Assessment 2015 - 2025 (NYSE:PEN)
www.prnewswire.com - September 20 at 11:59 AM
News IconShares in Focus: Penumbra Inc (NYSE:PEN) Earnings & Targets Update - Frisco Fastball (NYSE:PEN)
friscofastball.com - September 15 at 10:13 AM
News IconShares Holding Above Moving Averages: Penumbra, Inc. (NYSE:PEN) - Post News (NYSE:PEN)
www.kentuckypostnews.com - September 15 at 10:13 AM
News IconWhat's Penumbra Inc Upside After Today's Huge Increase? - Chester News (NYSE:PEN)
www.chesterindependent.com - September 15 at 10:13 AM
News IconGlobal Market Study on Neurosurgical Products: Asia Pacific to Witness Highest Growth by 2022 (NYSE:PEN)
www.advfn.com - September 14 at 6:51 PM
News IconStock on the Rise Over the Last Half Year: Penumbra, Inc. (NYSE:PEN) - Post News (NYSE:PEN)
www.kentuckypostnews.com - September 12 at 11:19 AM
streetinsider.com logoForm 4 Penumbra Inc For: Sep 07 Filed by: Elsesser Adam (NYSE:PEN)
www.streetinsider.com - September 10 at 10:56 AM
News IconPeripheral Embolization Device Market Value Share, Supply Demand, share and Value Chain 2016-2026 (NYSE:PEN)
www.medgadget.com - September 7 at 6:53 PM
streetinsider.com logoForm 4 Penumbra Inc For: Sep 01 Filed by: Rothman Lynn (NYSE:PEN)
www.streetinsider.com - September 7 at 6:53 PM
fidaily.com logoPenumbra, Inc. Common Stock (NYSE:PEN) Trading Up – Insiders Selling, Short Interest Growing (NYSE:PEN)
www.fidaily.com - September 7 at 6:53 PM
streetinsider.com logoForm 4 Penumbra Inc For: Sep 01 Filed by: Evans Robert D. - StreetInsider.com (NYSE:PEN)
www.streetinsider.com - September 7 at 10:14 AM
einnews.com logoNeurovascular Devices World Market Segmentation and Major Players Analysis 2022 (NYSE:PEN)
www.einnews.com - September 3 at 11:00 AM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 29 Filed by: Pray James Robert - StreetInsider.com (NYSE:PEN)
www.streetinsider.com - September 2 at 11:37 AM
capitalcube.com logoETF’s with exposure to Penumbra, Inc. : September 2, 2016 (NYSE:PEN)
www.capitalcube.com - September 2 at 11:37 AM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 29 Filed by: Pray James Robert (NYSE:PEN)
www.streetinsider.com - September 1 at 6:42 PM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 29 Filed by: Elsesser Adam (NYSE:PEN)
www.streetinsider.com - September 1 at 9:52 AM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 25 Filed by: Elsesser Adam - StreetInsider.com (NYSE:PEN)
www.streetinsider.com - August 30 at 10:03 AM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 22 Filed by: Elsesser Adam (NYSE:PEN)
www.streetinsider.com - August 26 at 9:46 AM
streetinsider.com logoForm 4 Penumbra Inc For: Aug 22 Filed by: Bose Arani (NYSE:PEN)
www.streetinsider.com - August 25 at 11:53 AM
fidaily.com logoPenumbra, Inc. Common Stock (NYSE:PEN) Trading Down – Insiders Selling, Short Interest Growing (NYSE:PEN)
www.fidaily.com - August 25 at 11:53 AM
News IconAnalysts & Crowd Weigh in on Where They See Penumbra Inc (NYSE:PEN) Going - Post News (NYSE:PEN)
www.kentuckypostnews.com - August 24 at 6:31 PM
fidaily.com logoStock is up at $74.16 Penumbra, Inc. Announces Participation... - Finance Daily (NYSE:PEN)
www.fidaily.com - August 18 at 6:56 PM
prnewswire.com logoPenumbra, Inc. Announces Participation at Upcoming Investor Conferences - PR Newswire (press release) (NYSE:PEN)
www.prnewswire.com - August 18 at 6:56 PM
publicnow.com logoPenumbra, Inc. Announces Participation at Upcoming Investor Conferences (NYSE:PEN)
www.publicnow.com - August 18 at 6:56 PM
fidaily.com logoInsiders Selling, Short Interest Growing Penumbra, Inc. Common ... - Finance Daily (NYSE:PEN)
www.fidaily.com - August 17 at 9:50 AM
capitalcube.com logoPenumbra, Inc. :PEN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NYSE:PEN)
www.capitalcube.com - August 12 at 6:54 PM
prnewswire.com logoPenumbra, Inc. Reports Second Quarter 2016 Financial Results - PR Newswire (press release) (NYSE:PEN)
www.prnewswire.com - August 11 at 10:00 AM
streetinsider.com logoPenumbra, Inc. (PEN) Reports Q2 EPS of $0.01, Raises FY ... - StreetInsider.com (NYSE:PEN)
www.streetinsider.com - August 10 at 7:13 PM
finance.yahoo.com logoPenumbra, Inc. Reports Second Quarter 2016 Financial Results - Yahoo Finance (NYSE:PEN)
finance.yahoo.com - August 10 at 7:13 PM
finance.yahoo.com logoPenumbra, Inc. Reports Second Quarter 2016 Financial Results (NYSE:PEN)
finance.yahoo.com - August 10 at 9:52 AM
finance.yahoo.com logoEdited Transcript of PEN earnings conference call or presentation 9-Aug-16 8:30pm GMT (NYSE:PEN)
finance.yahoo.com - August 10 at 9:52 AM
finance.yahoo.com logoPenumbra (PEN) Q2 Earnings Top Estimates, Margins Down (NYSE:PEN)
finance.yahoo.com - August 10 at 9:52 AM
streetinsider.com logoPenumbra, Inc. (PEN) Reports Q2 EPS of $0.01, Raises FY Revenue Guidance (NYSE:PEN)
www.streetinsider.com - August 9 at 7:02 PM
reuters.com logoBRIEF-Penumbra Inc Reports second quarter 2016 financial results (NYSE:PEN)
in.reuters.com - August 9 at 7:02 PM
sg.finance.yahoo.com logoPenumbra posts 2Q profit (NYSE:PEN)
sg.finance.yahoo.com - August 9 at 7:02 PM
biz.yahoo.com logoQ2 2016 Penumbra Inc Earnings Release - After Market Close (NYSE:PEN)
biz.yahoo.com - August 9 at 9:58 AM
openpr.com logoNeurointerventional Devices Market to Grow at a CAGR of 4.8% through 2025 (NYSE:PEN)
www.openpr.com - August 5 at 9:51 AM
finance.yahoo.com logoPenumbra (PEN) to Report Q2 Earnings: What's in the Cards? (NYSE:PEN)
finance.yahoo.com - August 2 at 7:05 PM
News IconIt's Earnings Time: What to Do with Penumbra, Inc. (NYSE:PEN) Stock - The Voice Registrar (NYSE:PEN)
voiceregistrar.com - August 2 at 11:44 AM
kcregister.com logoHealthcare New Highs: Penumbra, Inc. (NYSE:PEN), Pfizer Inc. (NYSE:PFE), Merck & Co. Inc. (NYSE:MRK), Alexion ... - KC Register (NYSE:PEN)
www.kcregister.com - July 29 at 6:55 PM
News IconRandomized penumbra 3-D trial of next generation stent retriever meets primary endpoints (NYSE:PEN)
www.sciencecodex.com - July 29 at 9:50 AM
streetinsider.com logoPenumbra, Inc. (PEN) Announces Penumbra 3D Trial Met Primary ... - StreetInsider.com (NYSE:PEN)
www.streetinsider.com - July 28 at 9:57 AM
openpr.com logoMarket Size of Neurovascular Devices, Forecast Report 2016-2026 (NYSE:PEN)
www.openpr.com - July 27 at 7:07 PM
News IconStroke Care: Randomized penumbra 3-D trial of next generation stent retriever meets primary endpoints (NYSE:PEN)
www.sciencedaily.com - July 27 at 7:07 PM

Social

Penumbra (NYSE:PEN) Chart for Tuesday, September, 27, 2016


Last Updated on 9/27/2016 by MarketBeat.com Staff